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One significant aspect of the acquired immune deficiency syndrome (AIDS)'
epidemic is its association with an increased incidence of neoplasia, primarily
Kaposi's sarcoma and malignant lymphoma (1). The occurrence of these neo-
plasms appears to be intimately connected with the condition of impaired
immunity present in AIDS, because similar tumors are known to be associated
with other types of immunodeficiency, including congenital, drug-induced, and
age-related immune deficiency syndromes (1-3). Therefore, studies of the path-
ogenesis of these neoplasms may provide important information concerning the
biology of AIDS and the relationship between immune surveillance and tumor
development in general. In particular, the study of neoplasia in patients with
AIDS represents a rare opportunity to follow the development of a human tumor
from the onset of a strongly predisposing condition, i.e., AIDS, to its biological
and clinical appearance.
Based on these considerations, we recently began a series of investigations into
the molecular pathogenesis of AIDS-related neoplasms, focusing on the lympho-
proliferative disorders that occur in association with AIDS and AIDS-related
complex (ARC). This group includes malignant lymphomas, most commonly B
cell non-Hodgkin's lymphomas (B-NHL) (4), and T cell leukemias and Hodgkins
disease (HD), which recently have been identified in AIDS patients (Knowles, D.
M., P.-G. Pelicci, M. Subar, R. Wieczorek, G. Chamulak, J. S. Burke, G.
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Wormser, Z . A. Arlin, and R. Dalla-Favera, manuscript submitted for publica-
tion). In addition, AIDS and ARC are characterized by enlarged but apparently
benign lymph nodes, commonly referred to as the lymphadenopathy syndrome
(LAS), that exhibit the histopathologic features of benign follicular hyperplasia
(1). The relationship between LAS and the development of B-NHL is intriguing
in terms of epidemiology, because a significant number of patients with LAS
develop B-NHL (1), and in terms of pathogenesis, since several biological features
of LAS could represent predisposing conditions leading to the development of
B-NHL . In particular, polyclonal B lymphocyte activation, aberrant B cell im-
munoregulation, and massive Epstein-Barr virus (EBV) infection represent con-
ditions present in LAS (1) that are also critically associated with some types of B-
NHL, namely African Burkitt lymphomas (BL) (5) .
In this study, the possible pathogenetic relationship between LAS and B-NHL
was further explored by the comparative analysis of samples of lymph nodes
from patients with LAS and B-NHL for the presence of clonal B cell populations,
oncogene rearrangements, and human immunodeficiency virus (HIV) sequences.
These are critical elements in elucidating a possible multistep process leading to
B cell lymphomagenesis in AIDS. The results of our studies support a model in
which the multiple clonal B cell expansions detectable in LAS increases the
probability of rearrangements/translocations of the c-myc oncogene, which rep-
resents the consistent pathogenetic marker of AIDS-associated B-NHLs. While
EBV is likely to be involved in the development of clonal B cell expansions, HIV
sequences are not detectable in AIDS-associated B-NHLs and do not appear to
play a direct role in lymphomagenesis.
Materials and Methods
Pathologic Samples and Diagnosis.
￿
Representative samples of lymph nodes, peripheral
venous blood, and aspirated bone marrow were collected, after informed consent, from
high-risk-group adults with AIDS or ARC who received medical care at the New York
University Medical Center or at the Westchester County Medical Center. The diagnosis
of AIDS or ARC was rendered according to established criteria (6). Similar samples also
were obtained, during the course of standard diagnostic procedures, from adult patients
who were not at risk for AIDS and who received medical care at the New York University
Medical Center during the same time period.
Each lymph node biopsy was classified as benign lymphoid hyperplasia (LAS) or non-
Hodgkin's lymphoma (NHL) using histopathologic and immunophenotypic criteria. Each
NHL was subclassified histopathologically according to the Working Formation of NHLs
(7). Immunophenotypic analyses for the expression of surface immunoglobulin (sIg),
cytoplasmic immunoglobulin (clg), sheep erythrocyte (E) rosettes, and terminal deoxynu-
cleotidyl transferase (TdT) were determined as previously described (8). B and T cell-
associated and restricted differentiation antigen expression was determined with an
extensive panel of monoclonal antibodies (anti-HLA-DR, J5, OKT3, OKT4, OKT6,
OK-f8, OKT10, OKT11, OKM1, OKB1, OKB2, OKB4, OKB7, B1, B2, B4, BA-1, BA-
2, Leu-1, Leu-7, Leu-12, Leu-14, Leu-M1, BLI, BL2, BL3, BL4, and BL7), principal
characteristics and distribution of reactivity of which have been previously reviewed (9).
Reactivity with each monoclonal antibody was tested on viable mononuclear cell
suspensions by indirect immunofluorescence using an argon laser fluorescence-activated
cell sorter (FACS 420, Becton-Dickinson Immunocytometry Systems, Mountain View,
CA) or a Leitz Laborlux 12 immunofluorescent microscope (10). In the case of lymph
node biopsies, these immunophenotypic analyses were supplemented by immunohistologic
analyses of cryostat tissue sections using an indirect immunoperoxidase technique (11).PELICCI ET AL. 2051
DNA Extraction and Southern Blot Analysis.
￿
DNA was prepared by cell lysis, digestion
with proteinase K, extraction with phenol, and precipitation with ethanol (12). 20 ug of
DNA were digested with the appropriate restriction endonuclease, electrophoresed in
agarose gels, denatured, neutralized, transferred to a nitrocellulose filter, and hybridized
to nick-translated probes according to established procedures (12). Hybridization was
performed in 50% formamide, 3x SSC, at 37°C with washes in 0.2X SSC, 0.5% SDS, pH
7, at 60°C for 2 h. Analysis of Ig and T cell receptor ,Q chain (TO) gene rearrangements
was performed by Southern blot hybridization, using various DNA clones representative
of different portions of Ig and T, 3 gene loci as probes. Probes were 12P-labelled by nick
translation (12). The To gene locus was analyzed by hybridization of Eco RI-, Bam HI-,
and Hind III-digested DNA to a T# gene probe (a gift from Dr. Tak Mak, Ontario
Cancer Institute, Toronto, Canada) that hybridizes to both T" constant regions (13, 14) .
The IgH gene locus was studied by hybridization of Hind III- and Eco RI-digested DNA
to a J-specific probe (a gift from Dr. Stanley Korsmeyer, National Institutes of Health,
Bethesda, MD) (15). The organization of the c-myc gene was analyzed by hybridization of
the human c-myc probe MC413RC to Eco RI- or Hind III-digested DNA (16). The
presence of integrated HIV sequences was investigated by hybridization of a probe
representative of the HIV genome (AIDS-associated retrovirus, ARV, clone X7A/2, [Luci
et al., 17]) to Hind III- or Sst I-digested DNA. In all the Southern blot hybridization
experiments, the sensitivity of the assay was estimated at 1-5%, i.e., a hybridization
fragment was detectable when present at a single copy in at least 5% of the cells from
which DNA was extracted. These levels of sensitivity were measured by dilution experi-
ments using probes labelled at a specific activity of 1-2 x 108 cpm/Ag and an autoradi-
ographic exposure time of 5-7 d with intensifying screens (Quanta III, DuPont Co.,
Wilmington, DE).
Results
Multiple B Cell Clonal Expansions Are Present in B-NHL and LAS.
￿
We have
used Ig and Ta gene rearrangement analysis to investigate the presence of clonal
lymphoid populations within pathologic samples of lymph nodes obtained from
patients with LAS and NHL and to determine their B or T cell lineage. Although
the enlarged lymph nodes of LAS are commonly considered to be benign
polyclonal lymphoid proliferations, gene rearrangement analysis represents the
most accurate method to investigate the presence of clonal B and T cell popula-
tions, respectively. In fact, the clonal determination of B cell lineage based on K
or X light chain expression sometimes may be inaccurate and lacks sensitivity,
while there is no phenotypic marker of clonality for T cells (18). In the case of
NHLs, the immunogenotypic determination of lineage can confirm the data
obtained by cell surface marker analysis. The issue of clonality of these tumors
is relevant in view of recent studies reporting the existence of biclonal tumors
and their increased frequency in immunosuppressed patients (19-21).
The organization of the Ig and TQ loci was investigated in the panel of cases
of B-NHL and LAS listed in Tables I and II (see Materials and Methods for
diagnostic criteria). Southern blot hybridization analysis was performed using
probes specific for the JH locus (15) and for the constant region of the T'3 (T, 3C)
(13, 14) locus, respectively. The results of this analysis are summarized in Tables
I and 11, and representative data are illustrated in Figs . 1 and 2. Consistent with
the data from cell surface marker analysis, all of the cases of NHL that displayed
B cell-specific cell surface markers displayed clonal rearrangements occurring
both in the Ig heavy chain gene locus (Fig. 1) and in the light chain gene loci2052
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TABLE I
Phenotypic and Genotypic Characteristics ofB-NHL Biopsies
All biopsies showed B cell-specific lineage markers; none showed Tcell-specific markers. All had
T,,rec loci in germline configuration, and none were found to contain HIV DNAsequences.
* Classified accordingto the working formulation of NHL (21).
$ G, germline configuration; R, rearranged configuration.
Presence and the number of different rearrangement bands (see text) has been indicated by
numbers.
TABLE II
Analysisfor Ig and c-myc Gene Rearrangements and HIV-related
Sequences in LAS Biopsies
Diagnosis
￿
n
Ig gene rearrangements
Germline Rearranged
AIDS/LAS
￿
22 18 4
Non-AIDS controls*
￿
11
￿
11
￿
0
None of the biopsies from either group showed c-myc gene rearrange-
ments or contained HIV sequences.
* Biopsies of benign hyperplastic lymph nodes.
(data not shown). According, clonal Tj3 gene rearrangements were not found in
these tumors (not shown, see Table 1) .
Upon DNA digestion with two different restriction enzymes, the majority (6
to 10) of the cases of B-NHL displayed two or more rearrangements bands (see
Fig. 1 for representative data obtained with Eco RI). These bands appear to be
ofdifferent intensity and are accompanied by the germline band. Although these
multiple bandscould theoretically be due to mutations within the Ig locus leading
to changes in restriction patterns, the frequency of detection of this phenomenon
in AIDS-NHL vs. non-AIDS-related NHL, together with the detection of
analogous patterns in LAS (see below), indicate the existence of multiple clonal
B cell expansions within the same tumor (19-21). In one single case (DK 180)
the presence of two distinct clonal populations was directly demonstrated by the
separate analysis of two tumor biopsies (DK180, DK 181) derived from separate
sites(Fig. 1). Thus, multiple clonal B cell expansions appear to be more frequently
detectable in AIDS-associated B-NHL: (60% of cases) than in conventional B-
NHLs (10% in our collection of 30 cases; 5% in the previously reported series
Patient/biopsy
code Histopathology*
Gene configurations
Ig locust c-myc
Cytogenetics
DK 348 Small cell, noncleaved R 1, 2,3 R ND
DK 179 Small cell, noncleaved R 1, 2 R ND
DK 285 Small cell, noncleaved R l, 2 R ND
DK 120 Small cell, noncleaved R 1, 2,3 R 8:14
DK 451 Large cell, noncleaved R 1 G 8:22
DK 452 Large cell, noncleaved R 1 R 8:14
DK 180 Large cell, noncleaved R I G ND
DK 181 Large cell, noncleaved R 1, 2, 3 G ND
DK 642 Small cell, noncleaved R 1 R ND
DK 644 Smallcell, noncleaved R 1, 2 R ND
DK 645 Smallcell, noncleaved R 1 R NDPELICCI ET AL .
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FIGURE 1 . Immunoglobulin gene rearrangement analysis in AIDS-associated lymphomas .
DNA (20,ug) from the indicated cases (see Table I) andfrom normal human placenta (C) were
digested with Eco RI and hybridized to a J probe (15) according to the method of Southern
(12) . Arrows indicate rearranged bands ; the 17 kb reference 13 indicated at left .
FIGURE 2 .
￿
Immunoglobulin gene rearrangements analysis in cases of LAS . DNA (20 wg)
from the indicated cases and from normal human placenta (C) was digested with Eco RI (A)
or Hind III (B) restriction enzymes and hybridized to a JH probe (15) . The hybridized filter
was exposed to x-ray film for 10 d . Arrows indicate rearranged bands; the 17 and 10 kb
references are indicated in A and B, respectively .
[20]). In this respect, AIDS-associated B lymphomas appear to be analogous to
lymphoid neoplasms occurring in other forms of immunodeficiency (19-21) .
Notably, clonal rearrangements of Ig genes, but not of T, 3 genes, were
detectable in a significant fraction of LAS samples. Representative Eco RI and
Hind III Southern blots of these cases are illustrated in Fig . 2, while a summary
of the survey is reported in Table II . The rearranged bands commonly display
a weak hybridization signal, with or without an accompanying hybridization
smear . This indicates that individual B cell clones, present at low abundancy
(-5%, see Materials and Methods), are sometimes accompanied by other oligo-
clonal B cell populations. These findings appear to be specific for AIDS-related
LAS, since comparable clonal B or T cell populations were not detectable in2054
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FIGURE 3 .
￿
Analysis of c-myc gene rearrangements in AIDS-associated lymphomas and in
cases of LAS . DNA (20 Ag) from the indicated B-NHL cases (see Table I) (A), from LAS cases
(see Table II) (B), and from normal human placenta (C) was digested with Eco RI and
hybridized to a probe (MC413RC) representative of the third exon of the human c-myc gene
(16) . Rearranged c-myc bands are shown by arrows; 12.8 kb reference is also shown .
analogous surveys of biopsies from non-AIDS-related lymphadenopathies (see
Table II) . Therefore, we conclude that the frequent presence of oligoclonal B
cell populations represents a distinctive feature ofAIDS vs . non-AIDS-associated
B-NHL and LAS.
c-myc Oncogene Rearrangements ArePresentinAIDSB-NHLButNotinLAS.
￿
The
c-myc locus is involved in specific chromosomal translocations that are thought
to play a role in Burkitt's lymphoma (16, 22, 23) . A number of preliminary
observations suggest that at least some AIDS-associated malignant lymphomas
share some features with BL, including (a) a sometimes similar cytologic and
histopathologic appearance (24-26) ; (b) an apparently frequent association with
EBV infection (24-28); and (c) the presence of the same specific chromosomal
translocations (26-28) . The unexpected detection of clonal B cell populations
within LAS biopsies prompted us to extend c-myc gene analysis to LAS biopsies .
The involvement of the c-myc locus in chromosomal translocations is suggested
by cytogenetic analysis showing the presence of the (8 :14), (8 :22), or (2:8)
translocations .c-mycinvolvement mayalso be directly demonstrated by restriction
enzyme hybridization analysis using enzymes that can detect either mutations
within or deletion of the 5' portion of the gene (29) . Cytogenetic analysis was
performed in 3 of the 10 cases of B-NHL and restriction enzyme analysis was
performed in all 10 cases of B-NHL and in all LAS samples (see Tables I and
II) . DNA samples from AIDS-associated NHLs or LAS were digested with Eco
RI restriction enzyme and hybridized to a human c-myc probe representative of
the third exon of the human c-myc gene (16) (see Fig . 3) . c-myc rearrangements
were detectable in 8 out of 10 NHL cases. It is important to note that only one
rearrangement band was detectable in all cases, including the ones displaying
multiple Ig rearrangement bands . Because, based on our survey of ^"40 BL cases,
the probability of coincidental comigration of two or more rearranged c-myc
alleles is extremely low, these data suggest that only one of the B cell clones
contains a rearranged c-myc locus . In one of the two NHL cases where the
rearrangements are not detectable, the involvement of the c-myc oncogene is
demonstrated by the presence of a variant (8:22) chromosomal translocation,
which has been shown (30) to involve chromosome breakpoints located at the 3'PELICCI ET AL .
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FIGURE 4.
￿
Lack of detectable HIV DNA sequences in AIDS-associated lymphomas and in
cases of LAS . 20 wg ofDNA from the indicated cases and 5,ug ofDNAfrom an ARV-infected
cell line (C) were digested with Sst I and hybridized to an HIVDNA probe representative of
the A region of the HIV genome (17) . The hybridized filter was exposed to x-ray film for 10
d . 3.8 and 5.7 kb references are shown .
side of the c-myc locus without apparent rearrangement of the gene . In the
remaining case of B-NHL, no cytogenetic data is available and no c-myc rear-
rangement is detectable . This suggests either the presence of a variant translo-
cation or that the c-myc gene is not involved in this one neoplasm . Conversely,
rearrangements were not detectable in any of the samples of LAS (Fig . 3B and
Table II) .
In summary, c-myc oncogene translocations and/or rearrangements appear to
be a virtually necessary pathogenetic feature of AIDS-associated B-NHLs . Most
notably, only a single rearranged c-myc band is detectable in NHL, while none is
detectable in LAS. These findings suggest that while both B-NHL and LAS
biopsies contain multiple clonal B cell expansions, only one clone, and only in B-
NHL, carries a rearranged c-myc gene .
HIV Sequences Are Not Present in NHL and LAS B Cell Clones.
￿
The possible
retroviral etiology of AIDS prompted us to investigate the presence of HIV
sequences in AIDS-associated NHL and LAS. TheHIV DNA probe, represent-
ative ofpart ofthe viral genome,'has been shown (17) to recognizeHIV sequences
in HIV-infected cell lines. DNA from both NHL and LAS cases was digested
with Sst I (see Fig . 4) and Hind III (data not shown), both of which have sites
within the viral genome, thus allowing the detection of viral sequences independ-
ent of the proviral integration site (17) . HIV DNA sequences were not detectable
in any of the cases of LAS or B-NHL (see Fig . 4 for experimental data and
controls). Given the fact that in our experimental conditions this assayallows the
detection of single-copy sequences present in at least 5% of the cell population
and that our B-NHL samples contained at least 80% pathologic cells (by histo-
pathologic examination), we conclude that the genotnes of AIDS-associated B-2056
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NHLs do notcarry HIV or HIV-relatedsequences. Furthermore, HIV sequences
present in at least a single copy per haploid genome should be detectable within
those clones. Our data allow us to conclude also that HIV sequences are not
present in any of the clonal B cell populations detected in LAS.
Discussion
This study indicates that the lymphoid organs in patients with AIDS who have
an associated LAS or NHL are frequently infiltrated by oligoclonal B cell
populations. The presence of B cell clones was not detected or suspected in LAS,
based upon histopathologic or surface-marker analysis of involved lymph nodes,
which had suggested the presence of a marked but apparently benign follicular
hyperplasia (1). This alteration is generally indistinguishable from lymphadenop-
athy associated with acute viral illnesses or autoimmune conditions (1) where Ig
gene rearrangements were not detected (1). Accordingly, while a single clonal B
cell population is obviously expected to be present in B-NHL biopsies, the finding
of additional B cell clones represents an extremely rare event in NHLs unasso-
ciated with AIDS . Taken together, these observations suggest that a common
condition in AIDs and ARC favors the development of clonal B cell expansions.
Indirect support for this notion can be derived from recent work reporting that
oligoclonal immunoglobulins, presumably secreted by oligoclonal B cells, are
present in the serum of patients with AIDS (31) .
Among the possible causes that may lead to abnormal B cell proliferations in
AIDS, the conditions of impaired immune functions and massive EBV infections,
present in both LAS and NHL patients, are likely to represent important factors.
Direct support for a combined role of immunodeficiency and EBV in favoring
clonal B cell expansions derives from recent work by Birx et al. (32), suggesting
that both a profound defect of T cell immunity to EBV and an abnormally high
number of circulating EBV-infected B cells are present in AIDS patients. EBV-
infected B cells are long-lived and replicate in vivo as well as in vitro, where they
can be readily and efficiently established as cell lines (32). These observations
suggest that these EBV-infected B cell clones can account for the monoclonal B
cell populations detectable in patients with AIDS by Ig gene rearrangement
analysis. The expansion of these pools of immortalized yet not fully transformed
cells may increase the probability of additional genetic alterations leading to
malignant transformation.
In 9 out of 10 biopsies, the presence of malignant B-NHL is associated with
the presence of translocations or rearrangements of the c-myc oncogene locus.
This genetic alteration is consistently found in BL and only occasionally in other
undifferentiated B cell lymphomas and lymphoblastic leukemias (33). In the
context of AIDS-associated NHLs, c-myc gene rearrangements provide a marker
for the malignant clone, thereby allowing two important observations. First, in
each one of the NHL biopsies displaying multiple clonal Ig gene rearrangements,
only one rearranged c-myc allele is detectable, which suggests that only one clone
carries the genetic abnormality associated with malignant lymphoma. We then
presume that only one of the multiple B cell clones detected by Ig rearrangements
represents the truly malignant lymphoma, whereas the remaining may be EBV-
immortalized nonmalignant clones analogous to the ones found in LAS. Second,PELICCI ET AL.
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it is important to note that despite their clinical and histopathologic heteroge-
neity, including both Burkitt andnon-Burkitttypes(see Table I), AIDS-associated
NHLs usually appear homogeneous with respect to oncogene activation. Thus,
the biological alterations present in AIDS may favor the development of lym-
phomas carrying activated oncogenes. In this respect, the association between
EBV-infection and immunosuppression present in AIDS is reminiscent of anal-
ogous conditions present in endemic, African-type BL, which are also typically
characterized by chromosmal translocations involving the c-myc locus (16).
Another issue addressed by our study is whether HIV sequences can be found
in AIDS-associated NHLs, i.e., whether HIV can be directly involved in the
pathogenesis of NHL. The relevance of this issue is underscored by recent
reports suggesting that HIV can infect EBV+ B cells (34), and that HIV infection
is endemic in Africa (35) in some of the regions where BL is also endemic (5).
Our data showing the lack of HIV sequences in NHL samples indicate that HIV
has nodirect rolein lymphomagenesis. However, inview ofthe specific cytopathic
effect of HIV for T4+ lymphocytes (36) and of the suggested role of these cells
in inhibition of EBV-activated B cells (37), it is possible that HIV infection,
present in all the patients included in this study, may indirectly contribute to the
clonal B cell expansion.
In conclusion, the data and the arguments presented here support a model for
a multistep process of lymphomagenesis in AIDS in which LAS would represent
a predisposing condition for NHL. Immunosuppression and EBV infection
present in LAS can favor the expansion of B cell clones, which in turn may
increase the probability of the occurrence of additional genetic alterations,
namely translocations of the c-myc gene causing the tumorigenic conversion of
these cells. In vitro experiments involvingthe transfer ofactivated/or rearranged
c-myc genes into EBV-immortalized B lymphocytes from AIDS/LAS patients
represent an obvious experimental approach for testing this model.
Summary
AIDS (acquired immune deficiency syndrome) and ARC (AIDS-related com-
plex) are associated with a spectrum of lymphoproliferative disorders ranging
from lymphadenopathy syndrome (LAS), anapparentlybenign polyclonal lymph-
oid hyperplasia, to B cell non-Hodgkin's lymphoma (B-NHL), i.e., malignant,
presumably monoclonal B cell proliferations. To gain insight into the process of
lymphomagenesis in AIDS and to investigate a possible pathogenetic relationship
between LAS and NHL, we investigated (a) the clonality ofthe B or T lymphoid
populations by Ig or T, 3 gene rearrangement analysis, (b) the presence of
rearrangements involving the c-myc oncogene locus, and (c) the presence of
human immunodeficiency virus (HIV) sequences in both LAS and B-NHL
biopsies. Our data indicate that multiple clonal B cell expansions are present in
a significant percentage of LAS (^"20%) and B-NHL (60%) biopsies. c-myc
rearrangements/translocations are detectable in 9 of our 10 NHLs, but not in
any of the LAS cases. However, only one of the B cell clones, identified by Ig
gene rearrangements carries a c-myc gene rearrangement, suggesting that only
one clone carries the genetic abnormality associated with malignant B cell
lymphoma. Furthermore, the frequency ofdetection ofc-myc rearrangements in2058
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AIDS-associated NHLs of both Burkitt and non-Burkitt type suggest that the
biological alterations present in AIDS favor the development of lymphomas
carrying activated c-myc oncogenes. Finally, our data show that HIV DNA
sequences are not detectable in LAS nor in NHL B cell clones, suggesting that
HIV does not play a direct role in NHL development. Taken together, these
observations suggest a model of multistep lymphomagenesis in AIDS in which
LAS would represent a predisposing condition to NHL . Immunosuppression and
EBV infection present in LAS can favor the expansion of B cell clones, which in
turn may increase the probability of occurrence of c-myc rearrangements leading
to malignant transformation.
We thank Gary Wormser for providing LAS samples, Francis G. Kern for critical reading
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